 | • レポートコード：MRC2312MG02630 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、63ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のmiRNA阻害剤市場規模と予測を収録しています。・世界のmiRNA阻害剤市場：売上、2018年-2023年、2024年-2029年 ・世界のmiRNA阻害剤市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のmiRNA阻害剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ASO阻害剤」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 miRNA阻害剤のグローバル主要企業は、Thermo Fisher、 GenePharma、 GeneCopoeia、 BioPioneer Tech、 IDT、 QIAGEN、 Eurogentec、 SwitchGear Genomicsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、miRNA阻害剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のmiRNA阻害剤市場：タイプ別、2018年-2023年、2024年-2029年 世界のmiRNA阻害剤市場：タイプ別市場シェア、2022年 ・ASO阻害剤、低分子阻害剤 世界のmiRNA阻害剤市場：用途別、2018年-2023年、2024年-2029年 世界のmiRNA阻害剤市場：用途別市場シェア、2022年 ・バイオ製薬会社、学術研究機関 世界のmiRNA阻害剤市場：地域・国別、2018年-2023年、2024年-2029年 世界のmiRNA阻害剤市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるmiRNA阻害剤のグローバル売上、2018年-2023年 ・主要企業におけるmiRNA阻害剤のグローバル売上シェア、2022年 ・主要企業におけるmiRNA阻害剤のグローバル販売量、2018年-2023年 ・主要企業におけるmiRNA阻害剤のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Thermo Fisher、 GenePharma、 GeneCopoeia、 BioPioneer Tech、 IDT、 QIAGEN、 Eurogentec、 SwitchGear Genomics ************************************************************* ・調査・分析レポートの概要 miRNA阻害剤市場の定義 市場セグメント 世界のmiRNA阻害剤市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のmiRNA阻害剤市場規模 世界のmiRNA阻害剤市場規模：2022年 VS 2029年 世界のmiRNA阻害剤市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのmiRNA阻害剤の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のmiRNA阻害剤製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：ASO阻害剤、低分子阻害剤 miRNA阻害剤のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：バイオ製薬会社、学術研究機関 miRNA阻害剤の用途別グローバル売上・予測 ・地域別市場分析 地域別miRNA阻害剤市場規模 2022年と2029年 地域別miRNA阻害剤売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Thermo Fisher、 GenePharma、 GeneCopoeia、 BioPioneer Tech、 IDT、 QIAGEN、 Eurogentec、 SwitchGear Genomics ... |
This research report provides a comprehensive analysis of the miRNA Inhibitor market, focusing on the current trends, market dynamics, and future prospects. The report explores the global miRNA Inhibitor market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of miRNA Inhibitor, challenges faced by the industry, and potential opportunities for market players.
The global miRNA Inhibitor market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The miRNA Inhibitor market presents opportunities for various stakeholders, including Biopharmaceutical Companies, Academic and Research Institutes. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in miRNA Inhibitor market. Additionally, the growing consumer demand present avenues for market expansion.
The global miRNA Inhibitor market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the miRNA Inhibitor market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the miRNA Inhibitor market.
Market Overview: The report provides a comprehensive overview of the miRNA Inhibitor market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., ASOs Inhibitors, Small Molecule Inhibitors), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the miRNA Inhibitor market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the miRNA Inhibitor market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the miRNA Inhibitor market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the miRNA Inhibitor market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the miRNA Inhibitor market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the miRNA Inhibitor market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for miRNA Inhibitor, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the miRNA Inhibitor market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
miRNA Inhibitor market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
ASOs Inhibitors
Small Molecule Inhibitors
Market segment by Application
Biopharmaceutical Companies
Academic and Research Institutes
Global miRNA Inhibitor Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Thermo Fisher
GenePharma
GeneCopoeia
BioPioneer Tech
IDT
QIAGEN
Eurogentec
SwitchGear Genomics
Outline of Major Chapters:
Chapter 1: Introduces the definition of miRNA Inhibitor, market overview.
Chapter 2: Global miRNA Inhibitor market size in revenue.
Chapter 3: Detailed analysis of miRNA Inhibitor company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of miRNA Inhibitor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 miRNA Inhibitor Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global miRNA Inhibitor Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global miRNA Inhibitor Overall Market Size
2.1 Global miRNA Inhibitor Market Size: 2022 VS 2029
2.2 Global miRNA Inhibitor Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top miRNA Inhibitor Players in Global Market
3.2 Top Global miRNA Inhibitor Companies Ranked by Revenue
3.3 Global miRNA Inhibitor Revenue by Companies
3.4 Top 3 and Top 5 miRNA Inhibitor Companies in Global Market, by Revenue in 2022
3.5 Global Companies miRNA Inhibitor Product Type
3.6 Tier 1, Tier 2 and Tier 3 miRNA Inhibitor Players in Global Market
3.6.1 List of Global Tier 1 miRNA Inhibitor Companies
3.6.2 List of Global Tier 2 and Tier 3 miRNA Inhibitor Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global miRNA Inhibitor Market Size Markets, 2022 & 2029
4.1.2 ASOs Inhibitors
4.1.3 Small Molecule Inhibitors
4.2 By Type – Global miRNA Inhibitor Revenue & Forecasts
4.2.1 By Type – Global miRNA Inhibitor Revenue, 2018-2023
4.2.2 By Type – Global miRNA Inhibitor Revenue, 2024-2029
4.2.3 By Type – Global miRNA Inhibitor Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global miRNA Inhibitor Market Size, 2022 & 2029
5.1.2 Biopharmaceutical Companies
5.1.3 Academic and Research Institutes
5.2 By Application – Global miRNA Inhibitor Revenue & Forecasts
5.2.1 By Application – Global miRNA Inhibitor Revenue, 2018-2023
5.2.2 By Application – Global miRNA Inhibitor Revenue, 2024-2029
5.2.3 By Application – Global miRNA Inhibitor Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global miRNA Inhibitor Market Size, 2022 & 2029
6.2 By Region – Global miRNA Inhibitor Revenue & Forecasts
6.2.1 By Region – Global miRNA Inhibitor Revenue, 2018-2023
6.2.2 By Region – Global miRNA Inhibitor Revenue, 2024-2029
6.2.3 By Region – Global miRNA Inhibitor Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America miRNA Inhibitor Revenue, 2018-2029
6.3.2 US miRNA Inhibitor Market Size, 2018-2029
6.3.3 Canada miRNA Inhibitor Market Size, 2018-2029
6.3.4 Mexico miRNA Inhibitor Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe miRNA Inhibitor Revenue, 2018-2029
6.4.2 Germany miRNA Inhibitor Market Size, 2018-2029
6.4.3 France miRNA Inhibitor Market Size, 2018-2029
6.4.4 U.K. miRNA Inhibitor Market Size, 2018-2029
6.4.5 Italy miRNA Inhibitor Market Size, 2018-2029
6.4.6 Russia miRNA Inhibitor Market Size, 2018-2029
6.4.7 Nordic Countries miRNA Inhibitor Market Size, 2018-2029
6.4.8 Benelux miRNA Inhibitor Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia miRNA Inhibitor Revenue, 2018-2029
6.5.2 China miRNA Inhibitor Market Size, 2018-2029
6.5.3 Japan miRNA Inhibitor Market Size, 2018-2029
6.5.4 South Korea miRNA Inhibitor Market Size, 2018-2029
6.5.5 Southeast Asia miRNA Inhibitor Market Size, 2018-2029
6.5.6 India miRNA Inhibitor Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America miRNA Inhibitor Revenue, 2018-2029
6.6.2 Brazil miRNA Inhibitor Market Size, 2018-2029
6.6.3 Argentina miRNA Inhibitor Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa miRNA Inhibitor Revenue, 2018-2029
6.7.2 Turkey miRNA Inhibitor Market Size, 2018-2029
6.7.3 Israel miRNA Inhibitor Market Size, 2018-2029
6.7.4 Saudi Arabia miRNA Inhibitor Market Size, 2018-2029
6.7.5 UAE miRNA Inhibitor Market Size, 2018-2029
7 miRNA Inhibitor Companies Profiles
7.1 Thermo Fisher
7.1.1 Thermo Fisher Company Summary
7.1.2 Thermo Fisher Business Overview
7.1.3 Thermo Fisher miRNA Inhibitor Major Product Offerings
7.1.4 Thermo Fisher miRNA Inhibitor Revenue in Global Market (2018-2023)
7.1.5 Thermo Fisher Key News & Latest Developments
7.2 GenePharma
7.2.1 GenePharma Company Summary
7.2.2 GenePharma Business Overview
7.2.3 GenePharma miRNA Inhibitor Major Product Offerings
7.2.4 GenePharma miRNA Inhibitor Revenue in Global Market (2018-2023)
7.2.5 GenePharma Key News & Latest Developments
7.3 GeneCopoeia
7.3.1 GeneCopoeia Company Summary
7.3.2 GeneCopoeia Business Overview
7.3.3 GeneCopoeia miRNA Inhibitor Major Product Offerings
7.3.4 GeneCopoeia miRNA Inhibitor Revenue in Global Market (2018-2023)
7.3.5 GeneCopoeia Key News & Latest Developments
7.4 BioPioneer Tech
7.4.1 BioPioneer Tech Company Summary
7.4.2 BioPioneer Tech Business Overview
7.4.3 BioPioneer Tech miRNA Inhibitor Major Product Offerings
7.4.4 BioPioneer Tech miRNA Inhibitor Revenue in Global Market (2018-2023)
7.4.5 BioPioneer Tech Key News & Latest Developments
7.5 IDT
7.5.1 IDT Company Summary
7.5.2 IDT Business Overview
7.5.3 IDT miRNA Inhibitor Major Product Offerings
7.5.4 IDT miRNA Inhibitor Revenue in Global Market (2018-2023)
7.5.5 IDT Key News & Latest Developments
7.6 QIAGEN
7.6.1 QIAGEN Company Summary
7.6.2 QIAGEN Business Overview
7.6.3 QIAGEN miRNA Inhibitor Major Product Offerings
7.6.4 QIAGEN miRNA Inhibitor Revenue in Global Market (2018-2023)
7.6.5 QIAGEN Key News & Latest Developments
7.7 Eurogentec
7.7.1 Eurogentec Company Summary
7.7.2 Eurogentec Business Overview
7.7.3 Eurogentec miRNA Inhibitor Major Product Offerings
7.7.4 Eurogentec miRNA Inhibitor Revenue in Global Market (2018-2023)
7.7.5 Eurogentec Key News & Latest Developments
7.8 SwitchGear Genomics
7.8.1 SwitchGear Genomics Company Summary
7.8.2 SwitchGear Genomics Business Overview
7.8.3 SwitchGear Genomics miRNA Inhibitor Major Product Offerings
7.8.4 SwitchGear Genomics miRNA Inhibitor Revenue in Global Market (2018-2023)
7.8.5 SwitchGear Genomics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer